Plain-English translation of NCT06447740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to treating high blood pressure caused by narrowed kidney arteries. Instead of deciding whether to place a stent based only on images, doctors will use a special pressure measurement called FFR to determine who truly needs a stent. If you qualify and have an abnormal pressure reading, you'll randomly receive either a stent plus blood pressure medication, or medication alone.
Past studies have been unclear about which patients with narrowed kidney arteries truly benefit from a stent. This trial uses FFR—a proven decision-making tool from heart disease—to identify the right patients for this procedure, potentially helping more people control their blood pressure and protect their kidney function.
You likely qualify if…
You likely don't qualify if…
You will have a special heart catheterization procedure where doctors place a thin tube in your kidney artery and measure the pressure using FFR. Based on this measurement, you'll either receive a stent immediately plus blood pressure medication, or continue on medication alone. You'll be followed up for 1 year total, with blood pressure checks and medication reviews at 3 months and at the end of the study to see how well your blood pressure is controlled.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
China